Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Numotech is a medical device company specializing in advanced wound care through its proprietary Topical Hyperbaric Oxygen Therapy (THOT) technology. The company's primary product, the Numo system, is designed to deliver 100% humidified oxygen at controlled pressure directly to the site of chronic and non-healing wounds. This localized approach aims to stimulate cellular activity, reduce infection, and accelerate the healing process for conditions such as diabetic foot ulcers and pressure sores. Numotech provides a portable, non-invasive alternative to systemic hyperbaric oxygen therapy, allowing for treatment in various clinical environments and patient homes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Numotech.